• Quest Diagnostics senior vice president for diagnostic services Patrick Plewman sold 11,717 shares at $257.34 each on Nov. 9, 2026.
• He exercised non-qualified stock options covering 4,274 shares at $127.725 each and 6,793 shares at $127.805 each.
• His direct common stock holdings totaled 14,684 shares following the transactions, according to the Form 4 filed Nov. 12, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quest Diagnostics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001022079-26-000125), on November 12, 2026, and is solely responsible for the information contained therein.